Clinical Trials Directory

Trials / Completed

CompletedNCT04757935

Yoga for Youth With IBD: a Pilot Feasibility Study

The Effects of Yoga on Disease Activity in Youth With Inflammatory Bowel Disease: a Pilot Feasibility Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
9 (actual)
Sponsor
Stanford University · Academic / Other
Sex
All
Age
10 Years – 21 Years
Healthy volunteers
Not accepted

Summary

An 8-week yoga intervention to determine the feasibility and acceptability of yoga as a supplemental therapy in the management of inflammatory bowel disease in the adolescent population.

Detailed description

Youth with IBD experience abdominal pain, diarrhea, weight loss, and psychological suffering related to their disease process. While many biologic and non-biologic therapies are available to target the inflammatory component of IBD, youth with IBD could benefit from a more holistic therapy that addresses psychological wellness, which has been shown, in turn, to reduce disease burden. It is known that stress (multiple varieties) leads to IBD flares. It is also known that mind-body intervention reduces stress. The mind-gut connection is widely discussed in medical circles, however, current therapies have not capitalized on it. The investigators would like to know if an easily accessible mind-body intervention (yoga) can improve wellness, lower stress levels, and reduce intestinal inflammation in youth with IBD. The study will be an 8-week feasibility pilot. Participants will be asked to participate in online yoga videos and in-studio yoga sessions. Participants will be asked to complete multiple surveys throughout the intervention and continue receiving standard care from their primary gastroenterology team.

Conditions

Interventions

TypeNameDescription
BEHAVIORALYogaYoga for 30 minutes three times weekly for 8 weeks in addition to three, 1-hour in-studio yoga sessions.

Timeline

Start date
2017-01-01
Primary completion
2017-05-31
Completion
2017-05-31
First posted
2021-02-17
Last updated
2021-02-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04757935. Inclusion in this directory is not an endorsement.